Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance - Regan, F M; Williams, R M; McDonald, A (J Clin Endocrinol Metab, 2010)
et al.